WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1'4101 Infant (under 12 months) mortality rate: 672
GDP / capita (US$): 3'4961 Child (under 5 years) mortality rate: 932

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 23'696  23'108  22'531  21'966  21'419  16'687  12'268  8'294 
Births 874  858  843  827  812  678  532  406 
Surviving infants 820  803  786  770  753  613  477  358 
Pop. less than 5 years 3'861  3'765  3'678  3'593  3'512  2'879  2'193  1'623 
Pop. less than 15 years 10'089  9'868  9'670  9'476  9'287  7'276  5'534  3'779 
Female 15-49 years 5'558  5'397  5'231  5'068  4'912  3'720  2'586  1'723 

Number of reported cases

(Click for retrospective incidence data for Côte d'Ivoire)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  45  65  50  48  137  5'729  17'799  7'633 
Mumps
ChartChart
 
Pertussis
ChartChart
  3'052 
Polio*
ChartChart
  28  47 
Rubella
ChartChart
  192  50  54  98  298 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  12  15  30  364 
Tetanus (total)**
ChartChart
  12  15  384 
Yellow fever
ChartChart
  15  21 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Côte d'Ivoire)
Vaccine year result method % card seen                                                
BCG 2014  87  CES   91  95  79  84  90  99  76 
DTP1 2014  91  CES   91  98  99*  93  99*  83 
DTP3 2014  76  CES   91  96  91  87  99*  94  62 
DTP4         
IPV1          61  39 
HepB_BD         
HepB3 2014  76  CES   91  96  91  87  99*  94 
Hib3 2014  76  CES   91  96  91  87  99*  94 
JapEnc         
MCV1          87  82  72  85  85  62 
MCV2         
MenA         
PCV1          97  99*  15 
PCV2          92  92 
PCV3          94  81 
Pol3 2014  76  CES   91  89  88  85  98  94  61  56 
Rota1         
RotaC         
RCV1         
TT2plus 2015  86  CES   91  84  80  77  81  84  78 
PAB         
VAD1          99  75  99* 
YFV 2014  49  CES   91  79  58  58  84  81  55 
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Côte d'Ivoire)
BCG
ChartChart
  95  79  84  90  93  80  62 
DTP1
ChartChart
  98  99  93  89  93  85  77 
DTP3
ChartChart
  85  83  76  80  82  65  54 
HepB3
ChartChart
  85  83  76  80  82 
HepB_BD
ChartChart
 
Hib3
ChartChart
  85  83  76  80  82 
IPV1
  61  39 
MCV1
ChartChart
  77  72  62  76  74  68  56 
MCV2
ChartChart
 
PCV3
ChartChart
  83  72 
Pol3
ChartChart
  80  81  76  79  83  66  56 
RCV1
 
RotaC
 
YFV
ChartChart
  70  49  49  69  73  60 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 82  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 93
From 80 to 89% 5
From 50 to 79% 2
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB_Pediatric birth; Yes From 2018
HPV girls 10 years; Yes From 2018
IPV 14 weeks; Yes
Measles 9 months; Yes
MenA 9 months; Yes From May 2018
MR 9 months; Yes From January 2018
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10, 14 weeks; Yes From July 2016
Td 1st contact pregnancy; +1, +6 months; +1, +1 years; Yes
VitA 6, 12 months; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2016-2020  2010-2015  2011-2015  2011-2015  2011-2015  2011 - 2015  2011-2015 
Nº of districts with microplans that include activities to raise immunization coverage number 82  82  82  82  82  102  83 

System performance

Total Nº districts in country number 82  82  82  82    102  83 
Nº districts with DTP3 coverage >=80% number 80  75  61  81    14  53 
% of districts with DTP3 coverage >=80% From 0 to 100% 98  91  74  99    14  64 
Nº districts with measles (MCV1) coverage >=95% number 29  19   
% of districts with MCV1 coverage >=95% From 0 to 100% 35  11  23   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  No  No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  No  No  No 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 46  63  10  83    35  53 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.